Association of anticardiolipin antibodies with vascular injury: possible mechanisms.
Haviv
Y S
YS
Nephrology and Hypertension Services, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. havivyo@md2.huji.ac.il
D017153:Antibodies, Anticardiolipin / Q000096:biosynthesis / Q000276:immunology*; D017152:Antibodies, Antiphospholipid / Q000276:immunology*; D016736:Antiphospholipid Syndrome / Q000276:immunology / Q000473:pathology; D017209:Apoptosis; D001161:Arteriosclerosis / Q000276:immunology; D015551:Autoimmunity; D004797:Enzyme-Linked Immunosorbent Assay; D020022:Genetic Predisposition to Disease; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000096:biosynthesis / Q000276:immunology; D013923:Thromboembolism / Q000276:immunology; D014652:Vascular Diseases / Q000276:immunology* / Q000473:pathology
D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D016682:Lupus Coagulation Inhibitor